Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (41)
  • Allergen immunotherapy (81)
  • AllergoOncology (15)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (235)
  • Allied health and primary care (20)
  • Anaphylaxis (113)
  • Artificial Intelligence (12)
  • Asthma (185)
  • Basic immunology (58)
  • Biologicals (90)
  • Biomarkers (64)
  • Comparative veterinary allergology (1)
  • COVID19 (11)
  • Dermatology (125)
  • Drug allergy (172)
  • x ENT (29)
  • Environmental allergy and climate change (31)
  • Eosinophilic esophagitis (21)
  • Epidemiology (66)
  • Epithelial cell biology (8)
  • Food allergy (195)
  • Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (80)
  • Immunomodulation and nutrition (13)
  • Infections (27)
  • Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (24)
  • Microbiome (9)
  • Occupational allergy (27)
  • x Ocular allergy (5)
  • One Health (13)
  • Pediatrics (144)
  • Prevention (40)
  • Systems medicine (13)
Poster available until
Poster categories
  • e-Thematic Poster Session (4)
  • Thematic Poster Session (25)
keywords
Session Reference
  • L-TPS02 (1)
  • L-TPS08 (1)
  • L-TPS10 (1)
  • L-TPS11 (1)
  • L-TPS18 (1)
  • L-TPS20 (1)
  • L-TPS21 (1)
  • TPS02 (1)
  • TPS05 (1)
  • TPS09 (3)
  • TPS17 (1)
  • TPS23 (1)
  • TPS41 (1)
  • TPS43 (2)
  • TPS49 (1)
  • TPS55 (5)
  • TPS57 (2)
  • TPS64 (1)
  • TPS67 (3)
  • TPS68 (1)
34 results
Thumbnail

D3.367 - Mental health, sexual functionality, quality of life, and patient experiences with chronic rhinosinusitis with nasal polyps at UNIMEQ-ORL in Bogotá, Colombia, 2022-2024: a mixed-methods study

Thumbnail

D3.372 - SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps

Thumbnail

D1.60 - Impact of real-world confounders on the accuracy of an AI model to support the read out of skin prick automated test results

Thumbnail

D2.139 - Oxidative stress and tissue hypoxia are triggered through the increased respiratory effort during sleep and reflect the inflammation as a stress link in the gut-brain axis in children suffering asthma, allergic/non-allergic rhinitis, and/or eczema

Thumbnail

D2.438 - Adipose-derived stem cells secretome attenuates eosinophilic inflammation in a chronic rhinosinusitis with nasal polyps mouse model

Thumbnail

D1.350 - A patient-centric approach to chronic rhinosinusitis with nasal polyps (CRSwNP): developing tools to improve disease management and outcomes

Thumbnail

D1.392 - Allergic Rhinitis Patients Appear to be at Risk of Lower Quality of Life and Higher Probability of Moderate or Severe Anxiety: Results of an Online Survey in Lithuania

Thumbnail

D2.371 - Clinical Implication of Neutrophil Phenotypes in Chronic Rhinosinusitis With Nasal Polyps

Thumbnail

D2.373 - Diurnal variation in Japanese cedar pollinosis symptoms

Thumbnail

D1.128 - Dupilumab in a Child with Severe Allergic Asthma, Atopic Dermatitis, Vernal Keratoconjunctivitis, and Partial IgA Deficiency

Thumbnail

D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix

Thumbnail

D3.303 - Contact Dermatitis and Rhinoconjunctivitis due to Palisander Wood Exposure in a Cabinetmaker

Thumbnail

D2.187 - Can the Conjunctival Allergen Provocation Test Improve Long-Term Adherence to Subcutaneous Allergen-Specific Immunotherapy?

Thumbnail

D1.439 - Is allergic conjunctivitis tip of the allergic iceberg ?

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Current page 2
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM